Nifty Top Gainers And Losers On May 12: Infosys, Shriram Finance Power Surge; IndusInd Bank, Sun Pharma Slide

Mumbai, 12th May: Indian equity markets witnessed a historic rally on May 12, with benchmark indices Sensex and Nifty posting their biggest single-day gains in nearly four years. The Sensex surged by 2,975.43 points to close at 82,429.90, while the Nifty jumped 916.70 points to end at 24,925, marking a gain of 3.82%. The rally was broad-based, with gains across mid-cap, small-cap, and sectoral indices—driven by improved global cues and geopolitical calm.

The session saw IT and metal stocks lead the charge, with investor sentiment buoyed by a ceasefire agreement between India and Pakistan and positive momentum from US-China trade negotiations. Sectoral indices including IT, Realty, Metal, and TECK rose sharply, reflecting risk-on sentiment among market participants.

Nifty Gainers and Losers

Key Triggers
Infosys (+7.69%), HCL Technologies (+6.43%), and other IT majors powered the rally as investors turned to defensive sectors amid global volatility. The surge was fuelled by improved earnings guidance, increased global tech spending, and strong deal pipelines, reinforcing optimism in India’s IT sector.

Adani Enterprises (+7.60%) rebounded sharply as renewed investor interest returned to infrastructure and energy names, reversing last week’s profit-booking and buoyed by hopes of policy support and capital expenditure momentum.

Shriram Finance (+7.16%) advanced on the back of strong quarterly earnings and sustained bullish sentiment in the NBFC space, with improving rural credit demand and easing rate pressures offering tailwinds.

Trent (+6.42%) extended gains following its strong Q4 results, supported by same-store sales growth and aggressive expansion in its retail footprint, which reinforced investor confidence in organised retail.

On the downside, IndusInd Bank (-3.40%) slipped after it flagged discrepancies in its derivatives portfolio, sparking governance concerns and weighing on sentiment in select private lenders.

Sun Pharma (-3.36%) dropped amid investor concerns around global pharmaceutical pricing pressure, triggered by geopolitical developments and potential regulatory shifts in key export markets.

The Bottom Line
May 12 marked one of the strongest sessions for Indian markets in recent years, driven by a potent mix of geopolitical relief, robust earnings, and global optimism. The resurgence in IT, infrastructure, and retail counters reflected broad-based investor confidence. However, undercurrents of risk in select financial and pharma names suggest a need for caution. But the question still remains – Can this momentum sustain amid global and domestic uncertainties?